Tweedy, Browne Co’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.48M Buy
6,417
+1,621
+34% +$601K 0.19% 44
2026
Q1
$1.4M Buy
4,796
+1,668
+53% +$548K 0.11% 63
2025
Q4
$1.1M Buy
3,128
+432
+16% +$146K 0.09% 48
2025
Q3
$871K Buy
+2,696
New +$839K 0.08% 52

Other funds holding ELV

Tweedy, Browne Co's ELV Position: Q2 2026 in Review

Tweedy, Browne Co increased its Elevance Health (ELV) stake by 34% in Q2 2026, buying an estimated $601K and bringing the position to 6,417 shares worth $2.48M. The position accounts for 0.19% of the portfolio, ranked #44.

Tweedy, Browne Co first reported a position in ELV in Q3 2025 and has held it in 4 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Tweedy, Browne Co held 6,417 shares of Elevance Health worth $2.48M as of Q2 2026.
  • Tweedy, Browne Co bought 1,621 Elevance Health shares in Q2 2026, an estimated $601K.
  • Elevance Health made up 0.19% of Tweedy, Browne Co's portfolio in Q2 2026, its #44 holding.
  • Tweedy, Browne Co first reported a position in Elevance Health in Q3 2025 and has held it in 4 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Tweedy, Browne Co's 13F filing for Q2 2026, filed 7 Aug 2026.